Investigations | Patient 1 | Patient 2 | Patient 3 | Patient4 | Patient 5 | Patient 6 | |
---|---|---|---|---|---|---|---|
Year presented | 1995 | 2016 | 2016 | 2016 | 2016 | 2016 | 2016 |
K+ mmol/L (3.5–5) | 1.5 | 2.7 | 2.3 | 2.1 | 2.5 | 2 | 2.4 |
Na+mmol/L (135–145) | 135 | 138 | 135 | 140 | 140 | 136 | 140 |
Cl− mmol/L (96–106) | 110 | 109 | 110 | 106 | 108 | 110 | 112 |
pH (7.35–7.45) | 7.30 | 7.28 | 7.40 | 7.40 | 7.30 | 7.42 | 7.40 |
pCO2 mmHg (35–45) | 26 | 20 | 30 | 28 | 30 | 31 | 32 |
HCO3 mmol/L (20–28) | 13.0 | 8.8 | 16.0 | 14.6 | 15.7 | 16.0 | 16.5 |
Anion gap1 (4–12) | 12.0 | 20.2 | 9.0 | 19.4 | 16.3 | 10.4 | 11.5 |
Delta ratio2 | 0 | 0.53 | −1.1 | 0.78 | 0.5 | −0.2 | −0.06 |
Urine pH3 (4.5–8) | 6.5 | 6.5 | 6.8 | 6.5 | 6.6 | 7.5 | 7.5 |
Urine K+ mmol/L(25–125) | 32 | 40 | 75 | 55 | 45 | 46 | 30 |
Urine Na+ mmol/L(50–125) | 54 | 102 | 111 | 85 | 130 | 90 | 110 |
Urine Cl− mmol/L(25–40) | 55 | 85 | 110 | 105 | 120 | 58 | 65 |
UAG4 | 31 | 57 | 76 | 35 | 55 | 78 | 75 |
Serum Creatinine μmol/L (eGFR ml/min) | 88 (70) | 126 (39) | 60 (89) | 236 (25) | 125 (58) | 94 (72) | 86 (61) |
Ultra sound scan abdomen | Normal | B/L MNb CKD | Normal | CKD | CKD | B/L MNb | Normal |
Ca++ mmol/L (2.1–2.6) | 2.12 | 2.10 | 2.10 | 1.94 | 1.95 | 2.50 | 2.10 |
PO4 mmol/l (0.8–1.5) | 0.6 | 1.13 | 0.8 | 0.94 | 0.5 | 1.2 | 1.2 |
ALP u/l (80–380) | 84 | 1958 | 86 | 550 | 807 | 103 | 544 |
TSH (0.4–4) micro Iu/ml | NA | Normal | Normal | Normal | Normal | Normal | 6.31 |
PTH pg/ml (8.8–76.6) | NA | 96.8 | 24.7 | 78 | 28.7 | NA | NA |
X-ray | Reduced bone density, loosers zones and pathological fracture | Normal | Diffuse osteo-sclerosis | Diffuse osteo-sclerosis | Normal | Normal | |
Haemoglobin (g/dL) | 9.3 | 11.3 | 10.6 | 13 | 13.6 | 12.4 | |
Mean corpuscular volume (MCV) (80-96 fl) | 106.6 | 103 | 109 | 103.9 | 105 | 98 | |
Reticulocyte count (0.5–1.5%) | 1.5 | 1.2 | 1.4 | 1.2 | 0.9 | 1.2 | |
Blood Film | SAO | SAO | SAO | SAO | SAO | SAO |